These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 24170262)

  • 1. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome.
    Lu T; Wen S; Cui Y; Ju SH; Li KC; Teng GJ
    Int J Cardiovasc Imaging; 2014 Jan; 30(1):221-31. PubMed ID: 24170262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E-knockout mice.
    Li G; Wu XW; Lu WH; Ai R; Chen F; Tang ZZ
    BMC Cardiovasc Disord; 2014 Oct; 14():145. PubMed ID: 25326709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
    Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
    J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.
    Larmann J; Frenzel T; Schmitz M; Hahnenkamp A; Demmer P; Immenschuh S; Tietge UJ; Bremer C; Theilmeier G
    Anesthesiology; 2013 Jul; 119(1):129-41. PubMed ID: 23559030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation.
    Sezer ED; Sozmen EY; Nart D; Onat T
    Vasc Health Risk Manag; 2011; 7():333-43. PubMed ID: 21731885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
    Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
    Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
    Ikeda H; Ishii A; Sano K; Chihara H; Arai D; Abekura Y; Nishi H; Ono M; Saji H; Miyamoto S
    Atherosclerosis; 2018 Aug; 275():1-10. PubMed ID: 29852399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice.
    Shami A; Gustafsson R; Kalamajski S; Krams R; Segers D; Rauch U; Roos G; Nilsson J; Oldberg Å; Hultgårdh-Nilsson A
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):354-61. PubMed ID: 23202368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Wang J; Xu P; Xie X; Li J; Zhang J; Wang J; Hong F; Li J; Zhang Y; Song Y; Zheng X; Zhai Y
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins' Withdrawal Induces Atherosclerotic Plaque Destabilization in Animal Model-A "Rebound" Stimulation of Inflammation.
    Stasinopoulou M; Kadoglou NPE; Christodoulou E; Paronis E; Kostomitsopoulos NG; Valsami G; Liapis CD; Kakisis J
    J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):377-386. PubMed ID: 30905179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine Norovirus Infection Variably Alters Atherosclerosis in Mice Lacking Apolipoprotein E.
    Hsu CC; Paik J; Brabb TL; O'Brien KD; Kim J; Sullivan BG; Hudkins KL; Seamons A; Finley JC; Meeker SM; Maggio-Price L
    Comp Med; 2015 Oct; 65(5):369-81. PubMed ID: 26473341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.
    Deguchi JO; Aikawa M; Tung CH; Aikawa E; Kim DE; Ntziachristos V; Weissleder R; Libby P
    Circulation; 2006 Jul; 114(1):55-62. PubMed ID: 16801460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
    Verreth W; De Keyzer D; Davey PC; Geeraert B; Mertens A; Herregods MC; Smith G; Desjardins F; Balligand JL; Holvoet P
    Br J Pharmacol; 2007 Jun; 151(3):347-55. PubMed ID: 17384667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
    Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
    Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
    Nahrendorf M; Keliher E; Panizzi P; Zhang H; Hembrador S; Figueiredo JL; Aikawa E; Kelly K; Libby P; Weissleder R
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1213-22. PubMed ID: 19833312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.